278 related articles for article (PubMed ID: 18236162)
1. Current diagnosis of acromegaly.
Cordero RA; Barkan AL
Rev Endocr Metab Disord; 2008 Mar; 9(1):13-9. PubMed ID: 18236162
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic challenges in acromegaly: a case-based review.
Bonert V
Best Pract Res Clin Endocrinol Metab; 2009 Dec; 23 Suppl 1():S23-30. PubMed ID: 20129191
[TBL] [Abstract][Full Text] [Related]
3. [Consensus on the change of criteria for cure of acromegaly during the last decade].
Kovács GL; Dénes J; Hubina E; Kovács L; Czirják S; Góth M
Orv Hetil; 2011 May; 152(18):703-8. PubMed ID: 21498158
[TBL] [Abstract][Full Text] [Related]
4. The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly.
Jenkins D; O'Brien I; Johnson A; Shakespear R; Sheppard MC; Stewart PM
Clin Endocrinol (Oxf); 1995 Nov; 43(5):517-22. PubMed ID: 8548933
[TBL] [Abstract][Full Text] [Related]
5. Delayed diagnosis of acromegaly in a patient with focal segmental Glomerulosclerosis: a rare case report and literature review.
Zheng J; Cui Z; Lv JC; Duan HZ; Wang SX; Zhang JQ; Zhou FD; Guo XH; Zhao MH
BMC Nephrol; 2019 Nov; 20(1):435. PubMed ID: 31771524
[TBL] [Abstract][Full Text] [Related]
6. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
[TBL] [Abstract][Full Text] [Related]
7. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
[TBL] [Abstract][Full Text] [Related]
8. Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone.
Subbarayan SK; Fleseriu M; Gordon MB; Brzana JA; Kennedy L; Faiman C; Hatipoglu BA; Prayson RA; Delashaw JB; Weil RJ; Hamrahian AH
Endocr Pract; 2012; 18(6):817-25. PubMed ID: 22784832
[TBL] [Abstract][Full Text] [Related]
9. Somatotropic adenomas without acromegaly.
Trouillas J; Sassolas G; Loras B; Velkeniers B; Raccurt M; Chotard L; Berthezène F; Tourniaire J; Girod C
Pathol Res Pract; 1991 Dec; 187(8):943-9. PubMed ID: 1792190
[TBL] [Abstract][Full Text] [Related]
10. A multihormonal pituitary adenoma with growth hormone and adrenocorticotropic hormone production, causing acromegaly and Cushing disease.
Kageyama K; Nigawara T; Kamata Y; Terui K; Anzai J; Sakihara S; Suda T
Am J Med Sci; 2002 Dec; 324(6):326-30. PubMed ID: 12495300
[TBL] [Abstract][Full Text] [Related]
11. Current diagnostic guidelines for biochemical diagnosis of acromegaly.
Ferone D; Resmini E; Bocca L; Giusti M; Barreca A; Minuto F
Minerva Endocrinol; 2004 Dec; 29(4):207-23. PubMed ID: 15765030
[TBL] [Abstract][Full Text] [Related]
12. [Acromegaly screening in patients with hyperprolactinemia and pituitary adenoma].
Ukhanova YA; Ilovayskaya IA
Probl Endokrinol (Mosk); 2023 Sep; 70(2):4-10. PubMed ID: 38796756
[TBL] [Abstract][Full Text] [Related]
13. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
Freda PU; Post KD; Powell JS; Wardlaw SL
J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
[TBL] [Abstract][Full Text] [Related]
15. [Discrepancy between IGF-1 and GH during 75 g oral glucose tolerance test measures to acromegaly screening in a patient with macroprolactinoma--case report and literature review].
Gonçalves FT; Feibelmann TC; Fernandes ML; Fonseca AR; Arantes HP; Jorge PT
Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):494-9. PubMed ID: 17546251
[TBL] [Abstract][Full Text] [Related]
16. Can intra-operative GH measurement in acromegalic subjects predict completeness of surgery?
van den Berg G; van Dulken H; Frölich M; Meinders AE; Roelfsema F
Clin Endocrinol (Oxf); 1998 Jul; 49(1):45-51. PubMed ID: 9797846
[TBL] [Abstract][Full Text] [Related]
17. Size heterogeneity of circulating growth hormone in acromegaly. "Big-big" GH forms are associated with inappropriately low IGF-I levels.
Arosio M; Nissim M; Ballabio M; Orefice R; Bazzoni N; Faglia G
Acta Endocrinol (Copenh); 1991 Aug; 125(2):150-9. PubMed ID: 1897332
[TBL] [Abstract][Full Text] [Related]
18. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
19. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'.
Nomikos P; Buchfelder M; Fahlbusch R
Eur J Endocrinol; 2005 Mar; 152(3):379-87. PubMed ID: 15757854
[TBL] [Abstract][Full Text] [Related]
20. [Acromegaly].
Chanson P
Presse Med; 2009 Jan; 38(1):92-102. PubMed ID: 19004612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]